Abstract |
In our previous work, pyridoxylated polyhemoglobin (PP-PolyHB) was shown to have a P50 = 16-18 torr, and a half-life (T 1/2) of 20 hrs in the circulation of rats given a 75% isovolemic exchange transfusion. For the present study, a rapid and lethal hemorrhagic shock model has been specifically designed to assess the ability of PP-PolyHB to function as an emergency resuscitation fluid. Using 48 fully conscious rats with special chronic arterial and venous cannulations, shock was induced by bleeding 67% of total blood volume in less than 40 min; producing 100% mortality in nonresuscitated controls. Resuscitation was carried out using one of the following infusion fluids equivalent in volume to the bled volume: Ringer's solution, albumin solution, stroma-free Hb ( SFHb), pyridoxylated SFHb (PP- SFHb), PP-PolyHb, and whole blood. Long-term (greater than 8 day) survival rate of rats (n = 12) resuscitated with PP-PolyHb was 75% compared to 83% for autologous whole blood. Survival following resuscitation with the other fluids was substantially lower. These results indicate that PP-PolyHb could effectively resuscitate lethal hemorrhagic shock in conscious rats, and provide long-term survival afterwards, even in the absence of any additional fluid maintenance.
|
Authors | P E Keipert, T M Chang |
Journal | Biomaterials, medical devices, and artificial organs
(Biomater Med Devices Artif Organs)
Vol. 13
Issue 1-2
Pg. 1-15
( 1985)
ISSN: 0090-5488 [Print] United States |
PMID | 4084648
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Substitutes
- Hemoglobins
- polyhemoglobin-pyridoxal-5-phosphate
- Pyridoxal Phosphate
- Oxygen
|
Topics |
- Animals
- Blood Pressure
- Blood Substitutes
(therapeutic use)
- Consciousness
- Emergency Medical Services
- Fluid Therapy
- Hemoglobins
(therapeutic use)
- Male
- Oxygen
(blood)
- Pyridoxal Phosphate
(analogs & derivatives, therapeutic use)
- Rats
- Rats, Inbred Strains
- Shock, Hemorrhagic
(blood, physiopathology, therapy)
- Time Factors
|